The pentose phosphate pathway (PPP) is a glucose-oxidizing pathway that runs in parallel
to upper glycolysis to produce ribose 5-phosphate and nicotinamide adenine dinucleotide …

Glucose-6-phosphate dehydrogenase (G6PD) is a key regulatory enzyme in the pentose
phosphate pathway which produces nicotinamide adenine dinucleotide phosphate …

Primaquine is the only available antimalarial drug that kills dormant liver stages of
Plasmodium vivax and Plasmodium ovale malarias and therefore prevents their relapse …

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a prevalent condition worldwide
and is caused by loss-of-function mutations in the G6PD gene. Individuals with deficiency …

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common blood
disorder, presenting multiple symptoms, including hemolytic anemia. It affects 400 million …

Laccases are valuable enzymes as an excellent ecological alternative for bioremediation
issues because they can oxidize persistent xenobiotic compounds. The production and …

Approximately 80% of newborns worldwide have some degree of hyperbilirubinemia and
visible jaundice. 1 Severe cases of hyperbilirubinemia can progress to kernicterus and lead …

The only currently available drug that effectively removes malaria hypnozoites from the
human host is primaquine. The use of 8-aminoquinolines is hampered by haemolytic side …

Glucose-6-phosphate dehydrogenase (G6PD) deficiency, affecting an estimated 500 million
people worldwide, is a genetic disorder that causes human enzymopathies. Biochemical …

The enzyme glucose-6-phosphate dehydrogenase (G6PDH) plays crucial roles in glucose
homeostasis and the pentose phosphate pathway (PPP), being also involved in redox …